Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4060095 | 0.87 | TSHR (0.67) | TSHRKMT2AMEN1LMNACA12 | |
| SCHEMBL6463788 | 0.87 | TSHR (0.50) | TSHRKMT2AMEN1LMNACA12 | |
| SCHEMBL22092864 | 0.86 | TSHR (0.52) | TSHRKMT2AMEN1LMNACA12 | |
| SCHEMBL17489164 | 0.86 | TSHR (0.52) | TSHRKMT2AMEN1LMNACA12 | |
| SCHEMBL3682553 | 0.84 | TSHR (0.63) | TSHRKMT2AMEN1LMNACA12 | |
| SCHEMBL7648165 | 0.84 | TSHR (0.48) | TSHRKMT2AMEN1LMNACA12 | |
| SCHEMBL6818326 | 0.84 | TSHR (0.44) | TSHRKMT2AMEN1LMNACA12 | |
| SCHEMBL22092626 | 0.83 | TSHR (0.39) | TSHRKMT2AMEN1LMNACA12 | |
| SCHEMBL437823 | 0.83 | TSHR (0.40) | TSHRKMT2AMEN1LMNACA12 | |
| SCHEMBL2809541 | 0.82 | TSHR (0.48) | TSHRKMT2AMEN1LMNACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10243238-B2 | Electrolyte for lithium cell | ROBERT BOSCH GMBH (DE) | 2019-03-26 | — | — | US | disclosed |
| WO-2014114542-A1 | ELECTROLYTE FOR LITHIUM CELL | ROBERT BOSCH GMBH (DE) | 2014-07-31 | — | — | WO | disclosed |
| EP-0608568-B1 | Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents | AMERICAN CYANAMID CO (US) | 1998-03-11 | — | — | EP | disclosed |
| US-5594027-A | TREATMENT OF DIABETES, HYPERGLYCEMIA AND OBESITY | AMERICAN CYANAMID COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| US-5510376-A | TREATING DIABETES, HYPERGLYCEMIA, OBESITY | AMERICAN CYANAMID COMPANY (US) | 1996-04-23 | — | — | US | disclosed |
| EP-0608568-A1 | Aminocycloalkanobenzodioxoles as beta-3 selective adrenergic agents | AMERICAN CYANAMID COMPANY (US) | 1994-08-03 | — | — | EP | disclosed |